ResMed Inc. (NYSE:RMD - Get Free Report) has been assigned a statement proposal of "Moderate Buy" from nan thirteen investigation firms that are presently covering nan company, MarketBeat.com reports. One finance expert has rated nan banal pinch a waste rating, 5 person assigned a…
This communicative appeared connected marketbeat.com, 2024-10-26 07:17:13.